NEW: FDA cracking down on supplement makers whose products are being “illegally marketed as unapproved new drugs” to prevent, treat or cure Alzheimer’s, diabetes and cancer.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Harry Boxer’s stocks to watch include maker of Botox competitorHarry Boxer's stock to watch include ... the maker of a Botox competitor
Weiterlesen »
FDA targets illegally marketed dietary supplementsThe US Food and Drug Administration is taking new action against dietary supplements, sending warning letters to companies who claim, without proof, that their products can prevent or treat Alzheimer's, diabetes and cancer, the agency announced Monday.
Weiterlesen »
FDA takes actions against 17 companies selling products illegally claiming to treat Alzheimer's
Weiterlesen »
FDA sends warning letter to 17 companies for 'illegally selling' Alzheimer's treatments'These products, which are often sold on websites and social media platforms, have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat,' the FDA says.
Weiterlesen »
FDA Sends Warning Letters to Dietary Supplement CompaniesThe FDA sent letters to 17 nutritional supplement manufacturers alleging that the companies are illegally selling products with the improper claims they can prevent, treat and cure serious diseases, including Alzheimer’s.
Weiterlesen »
Altria-Juul deal gets FDA scrutiny as regulators prepare e-cigarette restrictionsTobacco giant Altria Group Inc.’s efforts to gain a toehold in the burgeoning e-cigarette market are facing scrutiny, as a top U.S. regulator signaled that curbs on sales of some vaping products are imminent.
Weiterlesen »
Pain Therapeutics shares slide 17% as company charges FDA with basic math errors
Weiterlesen »
Pain Therapeutics stock plunges after company slams FDA for refusing to approve drugShares of Pain Therapeutics Inc. fell 18% Tuesday after the company released a statement railing against the U.S. Food and Drug Administration’s refusal to approve drug candidate Remoxy.
Weiterlesen »
FDA chief accuses Juul, Altria of reneging on promise to combat teen vapingScott Gottlieb is calling Altria and Juul's CEOs to the agency's headquarters to explain their plan to combat youth vaping and, once again, threatened to pull e-cigarettes off the market if more isn't done to reduce 'epidemic' levels of teen use.
Weiterlesen »
FDA reports additional cases of cancer linked to breast implantsA deadly cancer linked to breast implants has been found in additional women in the United States, federal health officials said.
Weiterlesen »